145 related articles for article (PubMed ID: 12957679)
1. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.
Bełtowski J; Wójcicka G; Jamroz A
Atherosclerosis; 2003 Sep; 170(1):21-9. PubMed ID: 12957679
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats.
Beltowski J; Jamroz-Wiśniewska A; Borkowska E; Wójcicka G
Pharmacol Res; 2005 Jun; 51(6):523-32. PubMed ID: 15829432
[TBL] [Abstract][Full Text] [Related]
3. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats.
Wójcicka G; Jamroz-Wiśniewska A; Czechowska G; Korolczuk A; Marciniak S; Bełtowski J
Eur J Pharmacol; 2016 Oct; 789():187-194. PubMed ID: 27450486
[TBL] [Abstract][Full Text] [Related]
4. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.
Wójcicka G; Jamroz-Wiśniewska A; Marciniak A; Łowicka E; Bełtowski J
Life Sci; 2010 Jul; 87(3-4):126-32. PubMed ID: 20638992
[TBL] [Abstract][Full Text] [Related]
5. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities.
Bełtowski J; Wójcicka G; Jamroz A
J Cardiovasc Pharmacol; 2004 Jan; 43(1):121-7. PubMed ID: 14668577
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension.
Beltowski J; Wójcicka G; Marciniak A; Jamroz A
Life Sci; 2004 Apr; 74(24):2987-3000. PubMed ID: 15051422
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia.
Kiortsis DN; Tsouli S; Lourida ES; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2005; 56(4):451-8. PubMed ID: 16079929
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia.
Beltowski J; Wójcicka G; Jamroz-Wiśniewska A; Borkowska E; Marciniak A
Life Sci; 2005 Aug; 77(15):1855-68. PubMed ID: 15913657
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients.
Phumala Morales N; Cherlermchoung C; Fucharoen S; Chantharaksri U
Clin Chem Lab Med; 2007; 45(7):884-9. PubMed ID: 17617032
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Bayrak T; Dursun P; Bayrak A; Gültekin M; Kolusarı A; Cakır E; Ozyurt M; Zeyneloğlu HB
Gynecol Endocrinol; 2012 Nov; 28(11):874-8. PubMed ID: 22621680
[TBL] [Abstract][Full Text] [Related]
12. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration.
Bełtowski J; Wójcicka G; Marciniak A
Acta Biochim Pol; 2002; 49(4):927-36. PubMed ID: 12545199
[TBL] [Abstract][Full Text] [Related]
13. Leptin and paraoxonase activity in cord blood from obese mothers.
Ferretti G; Cester AM; Bacchetti T; Raffaelli F; Vignini A; Orici F; Martino C; Tranquilli A
J Matern Fetal Neonatal Med; 2014 Sep; 27(13):1353-6. PubMed ID: 24147648
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant treatment normalizes renal Na+,K+-ATPase activity in leptin-treated rats.
Bełtowski J; Jamroz-Wiśniewska A; Borkowska E; Nazar J; Marciniak A
Pharmacol Rep; 2005; 57(2):219-28. PubMed ID: 15886421
[TBL] [Abstract][Full Text] [Related]
15. Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients.
Varga Z; Paragh G; Seres I; Kakuk G; Karanyi Z; Karpati I; Matyus J; Csongradi E; Juhasz A; Balla J; Bajnok L
Nephron Clin Pract; 2006; 103(3):c114-20. PubMed ID: 16534235
[TBL] [Abstract][Full Text] [Related]
16. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertension.
Jamroz-Wiśniewska A; Wójcicka G; Łowicka E; Ksiazek M; Bełtowski J
Biochem Pharmacol; 2008 Apr; 75(8):1623-38. PubMed ID: 18282556
[TBL] [Abstract][Full Text] [Related]
18. The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Carlioglu A; Kaygusuz I; Karakurt F; Gumus II; Uysal A; Kasapoglu B; Armutcu F; Uysal S; Keskin EA; Koca C
Arch Gynecol Obstet; 2014 Nov; 290(5):929-35. PubMed ID: 24840107
[TBL] [Abstract][Full Text] [Related]
19. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
